Top-News

FS Development Corp II News

Aktie
WKN:  ISIN:  US69945Q1058 US-Symbol:  PRDS
Keine aktuellen Kursdaten verfügbar
Handeln Depot/Watchlist
Dieses Wertpapier ist nicht mehr handelbar.
Aktienanzahl *
-
Marktkapitalisierung *
-
Streubesitz
-
Index-Zugehörigkeit
-

FS Development Corp II News

29.08.23 - PR Newswire
SHAREHOLDER INVESTIGATION: Halper Sadeh LLC Investigates DEN, PRDS, HCCI
SHAREHOLDER INVESTIGATION: Halper Sadeh LLC Investigates DEN, PRDS, HCCI PR Newswire
15.08.23 - PR Newswire
SHAREHOLDER INVESTIGATION: Halper Sadeh LLC Investigates PRDS, CCF, NLTX, SCU
SHAREHOLDER INVESTIGATION: Halper Sadeh LLC Investigates PRDS, CCF, NLTX, SCU PR Newswire
07.08.23 - PR Newswire
SHAREHOLDER INVESTIGATION: Halper Sadeh LLC Investigates AEL, DEN, PRDS, FREQ
SHAREHOLDER INVESTIGATION: Halper Sadeh LLC Investigates AEL, DEN, PRDS, FREQ PR Newswire
03.08.23 - PR Newswire
Moore Kuehn Encourages PRDS, AMNB, NLTX, and SCU Investors to Contact Law Firm
Moore Kuehn Encourages PRDS, AMNB, NLTX, and SCU Investors to Contact Law Firm PR Newswire
31.07.23 - PR Newswire
SHAREHOLDER INVESTIGATION: Halper Sadeh LLC Investigates NEWR, AEL, PRDS
SHAREHOLDER INVESTIGATION: Halper Sadeh LLC Investigates NEWR, AEL, PRDS PR Newswire
24.07.23 - PR Newswire
SHAREHOLDER INVESTIGATION: Halper Sadeh LLC Investigates SCU, PRDS, NLTX, AJX
SHAREHOLDER INVESTIGATION: Halper Sadeh LLC Investigates SCU, PRDS, NLTX, AJX PR Newswire
17.07.23 - PR Newswire
SHAREHOLDER INVESTIGATION: Halper Sadeh LLC Investigates PRDS, KDNY, AEL
SHAREHOLDER INVESTIGATION: Halper Sadeh LLC Investigates PRDS, KDNY, AEL PR Newswire
17.07.23 - PR Newswire
Shareholder Alert: Ademi LLP investigates whether Pardes Biosciences, Inc. has obtained a Fair Price in its transaction with MediPacific
Shareholder Alert: Ademi LLP investigates whether Pardes Biosciences, Inc. has obtained a Fair Price in its transaction with MediPacific PR Newswire
12.04.23 - PR Newswire
Thinking about buying stock in Newmark Group, Exscientia, Pardes Biosciences, Creative Medical Technology, or Somalogic?
Thinking about buying stock in Newmark Group, Exscientia, Pardes Biosciences, Creative Medical Technology, or Somalogic? PR Newswire
30.01.23 - PR Newswire
RM LAW Announces Investigation of Pardes Biosciences, Inc.
RM LAW Announces Investigation of Pardes Biosciences, Inc. PR Newswire

Newssuche

Videos

13.06.24 0,00%
Technical Trading: Zukauf-​Chance bei Top-Trade, wenn
Sugar No.11 Long Typ: Turbo Open End WKN: VV50DP Hebel: 5 Laufzeit: OpenEnd Einstieg: prozyklisch ... Mehr »